Sam Peltzman, a leading economist known for the Peltzman Effect, explains how the U.S. Food and Drug Administration drug approval process delays life saving treatments long enough to cost millions of lives. Drawing on decades of research, he shows how regulation often creates unintended consequences, where policies meant to protect the public can reduce overall welfare.